Table 1.
1-month age-adjusted transition probabilities [20,21] |
Age | PDCIS-L | PL-R | PR-D | |
≤49 | 0.045 | 0.025 | 0.012 | ||
50–54 | 0.036 | 0.020 | 0.010 | ||
55–59 | 0.023 | 0.013 | 0.006 | ||
60–69 | 0.020 | 0.011 | 0.005 | ||
≥70 | 0.015 | 0.008 | 0.004 | ||
All | 0.028 | 0.016 | 0.007 | ||
DCIS | Local | Regional | Distant | ||
Mean age at diagnosisa [24] | Age | 58.58 | 60.21 | 57.67 | 61.06 |
Life expectancyb[24] | 40–49 | 13.94 yrs | 12.85 yrs | 10.02 yrs | 3.46 yrs |
50–54 | 13.87 yrs | 12.70 yrs | 9.62 yrs | 2.61 yrs | |
55–59 | 13.19 yrs | 12.19 yrs | 9.31 yrs | 2.69 yrs | |
60–69 | 12.28 yrs | 11.36 yrs | 8.58 yrs | 2.67 yrs | |
≥70 | 9.26 yrs | 8.35 yrs | 6.21 yrs | 1.80 yrs | |
All | 12.42 yrs | 11.13 yrs | 8.76 yrs | 2.58 yrs | |
Lifetime breast cancer- attributable costs [22] |
$67,598 | $67,598 | $86,516 | $69,449 | |
Total medical costs [23] | $127,596 | $111,072 | $101,063 | $65,940 | |
Stage shiftc | DCIS | Local | Regional | Distant | |
Initial distributiona at time 0 | 0.183 | 0.452 | 0.295 | 0.07 | |
Distribution at time 3-months | 0.168 | 0.445 | 0.310 | 0.076 | |
Distribution at time 6-months | 0.154 | 0.438 | 0.325 | 0.083 | |
Distribution at time 9-months | 0.142 | 0.430 | 0.339 | 0.090 |
Data Sources:
(SEER, 2000–2004, African-American and Latina women ≥ 40yrs);
(SEER, 1990–2004, African American and Latina women ≥ 40yrs);
(TreeAge Software, Inc. Williamstown, MA, USA).